These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12140 related articles for article (PubMed ID: 10197235)
1. Melan-A, a new melanocytic differentiation marker. Busam KJ; Jungbluth AA Adv Anat Pathol; 1999 Jan; 6(1):12-8. PubMed ID: 10197235 [TBL] [Abstract][Full Text] [Related]
2. Immunoreactivity for A103, an antibody to melan-A (Mart-1), in adrenocortical and other steroid tumors. Busam KJ; Iversen K; Coplan KA; Old LJ; Stockert E; Chen YT; McGregor D; Jungbluth A Am J Surg Pathol; 1998 Jan; 22(1):57-63. PubMed ID: 9422316 [TBL] [Abstract][Full Text] [Related]
3. Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma. Busam KJ; Chen YT; Old LJ; Stockert E; Iversen K; Coplan KA; Rosai J; Barnhill RL; Jungbluth AA Am J Surg Pathol; 1998 Aug; 22(8):976-82. PubMed ID: 9706977 [TBL] [Abstract][Full Text] [Related]
4. Expression of melanocyte-associated markers gp-100 and Melan-A/MART-1 in angiomyolipomas. An immunohistochemical and rt-PCR analysis. Jungbluth AA; Iversen K; Coplan K; Williamson B; Chen YT; Stockert E; Old LJ; Busam KJ Virchows Arch; 1999 May; 434(5):429-35. PubMed ID: 10389626 [TBL] [Abstract][Full Text] [Related]
5. Melan-A/Mart-1 expression in various melanocytic lesions and in non-melanocytic soft tissue tumours. Orosz Z Histopathology; 1999 Jun; 34(6):517-25. PubMed ID: 10383696 [TBL] [Abstract][Full Text] [Related]
6. Improved immunohistochemical evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma with 'MCW melanoma cocktail'--a mixture of monoclonal antibodies to MART-1, Melan-A, and tyrosinase. Shidham VB; Qi D; Rao RN; Acker SM; Chang CC; Kampalath B; Dawson G; Machhi JK; Komorowski RA BMC Cancer; 2003 May; 3():15. PubMed ID: 12735792 [TBL] [Abstract][Full Text] [Related]
7. A103: An anti-melan-a monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues. Jungbluth AA; Busam KJ; Gerald WL; Stockert E; Coplan KA; Iversen K; MacGregor DP; Old LJ; Chen YT Am J Surg Pathol; 1998 May; 22(5):595-602. PubMed ID: 9591730 [TBL] [Abstract][Full Text] [Related]
8. Comparison of melanoma antigen recognized by T cells (MART-1) to HMB-45: additional evidence to support a common lineage for angiomyolipoma, lymphangiomyomatosis, and clear cell sugar tumor. Fetsch PA; Fetsch JF; Marincola FM; Travis W; Batts KP; Abati A Mod Pathol; 1998 Aug; 11(8):699-703. PubMed ID: 9720495 [TBL] [Abstract][Full Text] [Related]
9. Melan-A: not a helpful marker in distinction between melanoma in situ on sun-damaged skin and pigmented actinic keratosis. El Shabrawi-Caelen L; Kerl H; Cerroni L Am J Dermatopathol; 2004 Oct; 26(5):364-6. PubMed ID: 15365366 [TBL] [Abstract][Full Text] [Related]
10. Differential expression of melanocytic markers in myoid, lipomatous, and vascular components of renal angiomyolipomas. Roma AA; Magi-Galluzzi C; Zhou M Arch Pathol Lab Med; 2007 Jan; 131(1):122-5. PubMed ID: 17227112 [TBL] [Abstract][Full Text] [Related]
11. Expression of Melan-A and Ki-67 in desmoplastic melanoma and desmoplastic nevi. Kucher C; Zhang PJ; Pasha T; Elenitsas R; Wu H; Ming ME; Elder DE; Xu X Am J Dermatopathol; 2004 Dec; 26(6):452-7. PubMed ID: 15618925 [TBL] [Abstract][Full Text] [Related]
12. Immunoreactivity of A103, an antibody to Melan A, in canine steroid-producing tissues and their tumors. Ramos-Vara JA; Beissenherz ME; Miller MA; Johnson GC; Kreeger JM; Pace LW; Turk JR; Turnquist SE; Watson GL; Yamini B J Vet Diagn Invest; 2001 Jul; 13(4):328-32. PubMed ID: 11478605 [TBL] [Abstract][Full Text] [Related]
13. Melan A/MART-1 immunoreactivity in formalin-fixed paraffin-embedded primary and metastatic melanoma: frequency and distribution. Hofbauer GF; Kamarashev J; Geertsen R; Böni R; Dummer R Melanoma Res; 1998 Aug; 8(4):337-43. PubMed ID: 9764809 [TBL] [Abstract][Full Text] [Related]
14. Staining of melanocytic neoplasms by melanoma antigen recognized by T cells. Mehregan DR; Hamzavi I Am J Dermatopathol; 2000 Jun; 22(3):247-50. PubMed ID: 10871068 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical diagnosis of malignant melanoma of the conjunctiva and uvea: comparison of the novel antibody against melan-A with S100 protein and HMB-45. Heegaard S; Jensen OA; Prause JU Melanoma Res; 2000 Aug; 10(4):350-4. PubMed ID: 10985669 [TBL] [Abstract][Full Text] [Related]
16. Melan A (A103) is expressed in adrenocortical neoplasms but not in renal cell and hepatocellular carcinomas. Ghorab Z; Jorda M; Ganjei P; Nadji M Appl Immunohistochem Mol Morphol; 2003 Dec; 11(4):330-3. PubMed ID: 14663359 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma: higher diagnostic accuracy with Melan-A and MART-1 compared with S-100 protein and HMB-45. Shidham VB; Qi DY; Acker S; Kampalath B; Chang CC; George V; Komorowski R Am J Surg Pathol; 2001 Aug; 25(8):1039-46. PubMed ID: 11474288 [TBL] [Abstract][Full Text] [Related]
18. The usefulness of tyrosinase in the immunohistochemical assessment of melanocytic lesions: a comparison of the novel T311 antibody (anti-tyrosinase) with S-100, HMB45, and A103 (anti-melan-A). Clarkson KS; Sturdgess IC; Molyneux AJ J Clin Pathol; 2001 Mar; 54(3):196-200. PubMed ID: 11253130 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical investigation of PNL2 reactivity of canine melanocytic neoplasms and comparison with Melan A. Giudice C; Ceciliani F; Rondena M; Stefanello D; Grieco V J Vet Diagn Invest; 2010 May; 22(3):389-94. PubMed ID: 20453212 [TBL] [Abstract][Full Text] [Related]
20. Expression of melanocytic differentiation markers in malignant melanomas of the oral and sinonasal mucosa. Prasad ML; Jungbluth AA; Iversen K; Huvos AG; Busam KJ Am J Surg Pathol; 2001 Jun; 25(6):782-7. PubMed ID: 11395556 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]